These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 3079628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR, Lowe GD, Belch JJ, Barbenel JC, Forbes CD.
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia.
    Awidi A, Maqablah A, Dweik M, Bsoul N, Abu-Khader A.
    Platelets; 2009 Aug; 20(5):297-301. PubMed ID: 19548178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The electronic aggregometer: a novel device for assessing platelet behavior in blood.
    Cardinal DC, Flower RJ.
    J Pharmacol Methods; 1980 Feb; 3(2):135-58. PubMed ID: 7392654
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J, Hedges A, Whittle BJ, Al-Sinawi LA, Mekki QA, Burke C, Moody SG, Moti MJ, Hassan S.
    Br J Clin Pharmacol; 1984 Dec; 18(6):921-33. PubMed ID: 6085004
    [Abstract] [Full Text] [Related]

  • 13. Observations on human platelet aggregation in native whole blood: synergism and sensitivity to aggregating agents in vitro.
    Boyd DG, Davis RB.
    Thromb Res; 1988 May 01; 50(3):429-36. PubMed ID: 3394122
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased in vitro platelet aggregation in hypertriglyceridemias.
    Riess H, Merk W, Falkner C, Hiller E.
    Thromb Res; 1986 Feb 01; 41(3):281-9. PubMed ID: 3705010
    [Abstract] [Full Text] [Related]

  • 16. Effects of endothelin-1 on aggregation of normal and uremic platelets.
    Pawlak K, Małyszko JS, Małyszko J, Myśliwiec M.
    Pol J Pharmacol; 1996 Feb 01; 48(2):185-90. PubMed ID: 9112649
    [Abstract] [Full Text] [Related]

  • 17. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
    Saniabadi AR, Lowe GD, Belch JJ, Forbes CD, Prentice CR, Barbenel JC.
    Thromb Haemost; 1983 Oct 31; 50(3):718-21. PubMed ID: 6196854
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.
    Sturk A, Asyee GM, Schaap MC, van Maanen M, ten Cate JW.
    Thromb Res; 1985 Nov 01; 40(3):359-72. PubMed ID: 2934863
    [Abstract] [Full Text] [Related]

  • 20. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL, Packham MA.
    Thromb Haemost; 1992 Aug 03; 68(2):189-93. PubMed ID: 1412166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.